Search results

Skip to results

Type

Status

Last updated

Showing 1 to 3 of 3 results for itulazax (birch pollen)

  1. Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years ID6537

    In development Reference number: GID-TA11636 Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen (TA1087)

    Evidence-based recommendations on betula verrucosa (Itulazax 12 SQ Bet) for treating moderate to severe allergic rhinitis or conjunctivitis caused by pollen from trees in the birch allergy group in adults.

    Technology appraisal guidance
    Published
    6 August 2025

    Sections for TA1087

  3. Thousands could benefit from first immunotherapy for severe birch tree pollen allergy

    We have recommended the first under-the-tongue tablet immunotherapy shown to build long-term tolerance to allergens, which could help up to 27,000 people in England with moderate to severe birch tree pollen allergies.

    News
    Last updated
    21 July 2025